Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history
References
Additional references
Ando N, Gorai I, Hirabuki T, Onose R, Hirahara F. Prolactin disorders in patients with habitual abortion. Acta Obstetrica et Gynaecologica Japonica 1992;44(6):650‐6.
Bussen S, Siitterlin M, Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Human Reproduction 1999;14(1):18‐20.
Carranza‐Lira S, Gonzalez‐Sanchez JL, Martinez‐Chequerj C. Vaginal bromocriptine administration in patients with hyperprolactinemia. International Journal of Gynecology & Obstetrics 1999;65(1):77‐8.
Chahal J, Schlechte J. Hyperprolactinemia. Pituitary 2008;11:141‐6.
Daya S. Evidence‐based management of recurrent miscarriage: optimal diagnostic protocol. International Congress Series 2004;1266:318‐27.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34.
García‐Enguídanos A, Calle ME, Valero J, Luna S, Domínguez‐Rojas V. Risk factors in miscarriage: a review. European Journal of Obstetrics & Gynecology and Reproductive Biology 2002;102:111‐9.
Harbord RM, Egger M, Sterne JA. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25:3443‐57.
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org.
Hirahara F. The clinical management for recurrent spontaneous abortion. Acta Obstetrica et Gynaecologica Japonica 1996;48:169‐72.
Hirahara F, Andoh N, Sawai K, Hirabuki T, Uemura T, Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertility & Sterility 1998;70(2):246‐52.
Katharina TW. Progesterone for recurrent miscarriage:truth and deceptions. Best Practice & Research Clinical Obstetrics and Gynaecology 2008;22:375‐9.
Lecomte P, Lecomte C, Lansac J, Gallier J, Sonier CB, Simonetta C. Pregnancy after intravenous pulsatile gonadotropin‐releasing hormone in a hyperprolactinaemic woman resistant to treatment with dopamine agonists. European Journal of Obstetrics & Gynecology and Reproductive Biology 1997;74(2):219‐21.
Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinology and Metabolism Clinics of North America 2008;37(1):67‐99.
Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989;299:541‐5.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Seppälä M, Ranta T, Hirvonen E. Hyperprolactinaemia and luteal insufficiency. Lancet 1976;1(7953):229‐30.
Totha B, Jeschkec U, Rogenhoferb N, Scholzc C, Würfeld W, Thalerb CJ, et al. Recurrent miscarriage: current concepts in diagnosis and treatment. Journal of Reproductive Immunology 2010;85:25‐32.
Tyson JE, Fresen HG. Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women. American Journal of Obstetrics and Gynecology 1973;116:377‐87.
Yip S, Sahota D, Cheung L, Lam P, Haines C, Chung T. Accuracy of clinical diagnostic methods of threatened abortion. Gynecologic and Obstetric Investigation 2003;56(1):38‐42.
